SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " imer " 572 found 🔀 AI-powered Shuffle
Brain health: Alzheimer's 2026 new report on cognitive impairment & dementia in Tennessee
An estimated 7.4 million Americans age 65 and older are now living with clinical dementia due to Alzheimer's disease, according to a newly released report from
Munster secure convincing win over youthful Ulster
Munster seal a comprehensive 41-14 win over Ulster in the United Rugby Championship game between the teams in Limerick.
Most Americans Worried About Brain Health, But Few Know How To Protect It
By Dennis Thompson HealthDay ReporterTHURSDAY, April 23, 2026 (HealthDay News) — Nearly all Americans are worried about their brain health as they age, ranking as important or more so than their physical health, a new Alzheimer’s Association report says. However, they don’t know what steps they can ...
9 in 10 Americans say brain health is important, but Alzheimer’s report finds most don’t know how to maintain it
While nearly 9 in 10 adults say brain health is very important, only a small number say they actually know how to maintain it, according to a new report from the Alzheimer’s Association.
What does it take to protect brain health? 10 habits to start now
Most U.S. adults think brain health is at least as important as physical health, according to a new survey from the Alzheimer’s Association.
Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science
Alzheimer’s research shows what happens when funding pressures and vested interests corrupt the pursuit of scientific truth.
More than 7 million have Alzheimer's. Can your brain health improve?
People have no control over Alzheimer's risk factors such as age, genes and family history. Diet, exercise and adequate sleep improve brain health.
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimer’s and addiction.
Curing U.S. Health Care, Part I
In 2008, much to their own surprise, leading Democrats unified around a program of major health care reform. Policy wonks had spent years developing the concepts behind what eventually became Obamacare; big Democratic victories in the 2006 midterms and the prospect of controlling both Congress and the presidency made it possible to imagine turning those ideas into reality. During the Democratic primary, Hillary Clinton and Barack Obama advocated similar plans, based on those ideas, for expanding insurance coverage. And it happened! The Affordable Care Act was enacted in 2010. When it was fully implemented in 2014, millions of Americans got health insurance: Impressive as the raw numbers are, they don’t tell the whole story. Before the ACA, even upper-middle-class Americans often found it impossible to get health insurance if they had pre-existing medical conditions. Many Americans were trapped in jobs they wanted to leave but couldn’t for fear of losing their employment-based coverage. Meanwhile, dire predictions from the usual suspects about runaway costs proved wrong. In fact, overall U.S. medical spending has grown much more slowly since the ACA was enacted than before. But the U.S., alone among advanced nations, still falls far short of providing universal health care. As you can see from the chart above, 8 percent of the population was still uninsured in 2024, a number that is set to rise over the next two years as a result of Republican policies. True, many of the uninsured in 2024 were undocumented immigrants, who we don’t try to cover. But there are still a lot of uninsured. Moreover, a significant number of Americans who have health insurance are in fact underinsured. As a result, they are at risk of incurring devastating healthcare costs and are sometimes forced to forgo needed care. This number is set to rise sharply in the next two years as a result of Republican policies adopted under Donald Trump. And not only is the U.S. unique among advanced countries in its under-provision of health care coverage, it also incurs by far the world’s highest healthcare costs per capita. So now may well be a good time to get behind a new push for major health reform — an effort, if you like, to finish the job begun under Obama. Today’s primer is devoted to the economics of health reform. During his failed effort to repeal the Affordable Care Act, Donald Trump famously complained, “Nobody knew healthcare could be so complicated.” Actually, we did know — and it’s not that complicated. Health economists understand the principles very well. And because health policy varies greatly among advanced nations, we know a lot about what works and what doesn’t. This will be the first in a series about health reform. Beyond the paywall I’ll address the following: 1. Why markets can’t be trusted to deliver healthcare 2. Routes to universal healthcare 3. What works? In a follow-up post I’ll discuss the pros and cons of different approaches, and possible paths forward for the United States.
SGMC Health Offers New Treatment Option for Early Alzheimer’s Disease
SGMC Health now offers an FDA-approved treatment option for people in the early stages of Alzheimer’s disease, giving patients and families in South Georgia access to care that can help […]
Brain health: Staying more active during the day helps retain brain volume
Older adults with a more fragmented circadian rest-activity rhythm lost more brain volume in areas typically affected by Alzheimer’s disease, research has found.
YouTube Shorts are a lot easier to ignore with this new setting [Gallery]
YouTube Shorts is rolling out a zero-minute timer that effectively turns off the short videos, or at least makes them easier to ignore.
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer's Diagnosis
Re:Cognition Health, a global leader in new treatments for Alzheimer's Disease, is delivering an international clinical trial to evaluate whether a simple finger-prick blood test can revolutionize how Alzheimer's disease is diagnosed. Compared with the current invasive and expensive diagnostic methods, this approach could provide a scalable solution for an earlier, easier, more accurate, affordable, and accessible diagnostic method. Re:Cognition Health will help enroll approximately 1,000 partic
Longevity enthusiast Bryan Johnson shares a test for biological age
Johnson led the exercise at Business Insider's The Long Play event in San Francisco on Tuesday. You can do it anywhere with a timer.
Capital One closes Spark Miles, launches Venture Business
The Capital One Spark Miles is no longer open to new applicants, but the Venture Business has arrived to offer solid perks in its place.
USC Brain Health Center could be hub for Alzheimer’s treatment, new tech for mental health
A new $30 million Brain Health Center at USC in Columbia will be a magnet for advanced diagnosis and treatment of Alzheimer’s disease and dementia but also deploy new technology for mental health.
Yankees news: Boone angry with ABS failures
Yanks worst in baseball at challenges; bottom of lineup a Problem; farewell to Winquest; RIP to an old-timer.
Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology
A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines.
“AI polls” are fake polls
A few weeks after Donald Trump’s second presidential win, I took the train up from London (where I was living at the time) to Oxford to attend a conference on polls and forecasts of the 2024 election. Most of the attendees were pollsters or academics, but I also watched presentations from Aaru and Electric Twin, two companies that do what is interchangeably called synthetic sampling, silicon sampling, or synthetic audiences. Stripped of startup jargon, that means they use large language models (LLMs) to simulate responses to public opinion polls by having AI agents take on the role of survey respondents. I had already heard of Aaru thanks to some articles with eye-catching headlines like “No people, no problem: AI chatbots predict elections better than humans” in the months leading up to Election Day. The founders were making some big, some might even say far-fetched claims, such as: “within two years, we will simulate the entire globe — from the way crops are grown in Ukraine to how that impacts production of oil in Iraq, trade through the strait of Malacca, and elections for the mayor of Baltimore.” When Semafor asked Aaru’s cofounders — Cameron Fink and Ned Koh — about my boss, they said “we respect all those who came before us.” Nate (as he so often does) shared his thoughts on Twitter: Fink and Koh were relatively good-natured about this back-and-forth when we spoke at Oxford. They even offered to mail me one of the t-shirts featuring Nate’s quote they apparently had made. I never took them up on the offer, which I now somewhat regret. These synthetic sampling companies fell off my radar for a while, but they do still exist. In fact, Aaru recently received a $1 billion valuation. Is what they’re doing anywhere close to the most important frontier in AI development? Not by a longshot, especially when Anthropic just developed a model so adept at exploiting software vulnerabilities that it’s only being released to 40 companies. Still, silicon sampling is increasingly finding its way into public polling. Axios reported in March that “a majority of people trust their own doctors and nurses” based on findings from Aaru — without mentioning that the “people” in that sentence were actually LLMs. Around the same time, the Public Sentiment Institute “boosted” their online sample of 373 real survey respondents with 114 AI agents.1 (Spoiler alert: even the co-founder of Electric Twin doesn’t think that’s a particularly defensible approach.) Polling companies like Qualtrics and Ipsos are also developing synthetic data panels. So, what should we make of these … “polls”? Let’s get one thing out of the way: whatever they are, they’re not polls in the way that term is usually defined. Subscribe You can’t replace polls with AI On one hand, using LLMs to essentially make up fake survey respondents sort of sounds like the dumbest idea ever, one that will at best imperfectly replicate real polls while introducing all sorts of biases. On the other hand, with LLMs improving at a remarkable, perhaps even alarming rate, maybe that means I’m a dinosaur at the ripe old age of 24 because I still want to rely on polls that talk to actual people. I’m not going to argue that synthetic samples are completely useless. In fact, as I’ll return to later, there is evidence that some techniques can replicate topline survey results quickly and cheaply. But the marketing from certain companies can be slightly optimistic. “No traditional poll will exist by the time the next general election occurs,” said Fink in 2024. We’re just 206 days away from the midterms, and based on the fact that I still have to collect a bunch of polls every day, I’d say he should have run that prediction by a sample of AI agents before the interview.2 To see why synthetic samples can’t replace polls, here’s a quick primer on how they work. The simplest version of these models involves taking a LLM (like ChatGPT or Claude), giving it a demographic profile (e.g., a white, college-educated woman who lives in Utah and makes $70k a year), and then asking it to respond to a survey question. You repeat that process a few thousand times using different demographic profiles and end up with a sample of synthetic survey responses. The actual models used by private companies are more sophisticated than this, usually because they incorporate more hypothesized demographic characteristics for each agent and provide them with extra information. Aaru, for example, feeds agents a diet of news and information they’d be likely to consume, while Electric Twin incorporates their customers’ proprietary data about the audience they’re trying to replicate. The way Ben Warner, the co-founder of Electric Twin, explained it to me was “we have a large amount of data on […] for instance, 5,000 people. Can we make an accurate prediction of how they would respond to another question?” Still, it should be obvious why synthetic samples can’t replace polls. Polling is fundamentally a data collection process. We might use surveys to make predictions by feeding them into election forecasts, but the main purpose of a poll isn’t prediction, it’s gathering new data about what people think and how they feel. Silicon sampling, on the other hand, produces no new data. It’s simply a model: you input LLM training data, demographic prompts, and a bunch of other information, and it spits out a prediction for what a poll would say. We love models here, but models aren’t polls. That difference is an important philosophical sticking point for most pollsters I talk to. “I think politics should stay away from [synthetic sampling], because we’re trying to […] represent the voice of the people,” said Natalie Jackson, a vice president at GQR Insights. Democratic pollster John Hagner told me: “I think I’m just incredibly skeptical of this idea. I don’t think it’s research. At that point, you’re asking the machine to tell you what you already believe.” Hagner has seen some presentations of early synthetic sampling experiments, but so far, “if it’s being used in a campaign, people are keeping it incredibly quiet.”3 But Eli, I hear you saying, aren’t polls themselves increasingly governed by modeling decisions? Indeed they are: pollsters’ choices on which sampling method to use, how to define their likely voter models, and how to weight their samples can and do lead to dramatic differences in the results they publish. Aaru even referenced these limitations in the methodology statement included with that maternal mortality “poll” — although I’m using the term “methodology statement” loosely here, because it doesn’t really explain how the model works at all. We can ignore the (frankly preposterous) implication that synthetic sampling isn’t subject to a separate set of biases. The important point is that there’s still a meaningful difference between using weighting and other statistical techniques on actual polling data and using a model to predict what a poll would say. The latter is far closer to election forecasts or techniques like MRP — potentially useful models, but not a replacement for polls.4 To be fair, other synthetic sampling companies are perfectly happy with the distinction between polls and models. Warner compared polling and synthetic sampling to different tools in a toolbox. “The mistake I think we make is we think that these new tools should either work in exactly the same way or somehow replace these old tools,” he said. “Rather than thinking of it as, okay, so we’ve always had the hammer, we’ve always had the screwdriver, now we’ve got a saw. But don’t use a saw to try [to] do the job of a hammer.” A quick comment from Nate Eli didn’t ask me for a comment — rather rude of him, don’t you think? But since I’m editing this story, I figured I’d add a few quick thoughts rather than putting words in his mouth. Beyond the frequently misleading marketing, what bothers me about the AI “poll” hype is that as AI tools make statistical inference cheaper and/or better (note that these are not synonyms) that actually increases the comparative value of collecting original data. You might be able to train a model to make a reasonable estimate of what some hard-to-reach poll respondent would say — say, a young Black man who voted for Trump. (Such a person checks a number of boxes for a voter who is usually hard to reach in surveys.) Indeed, this is closely related to what models like the Silver Bulletin forecast already do. They essentially smooth out the kinks in noisy survey data by making inferences based on past voting patterns or national polls or surveys of other states. But you don’t actually know what these voters think unless you’re reaching them directly. If there’s a shift in opinion among this subgroup, you’re not going to detect it. So if I were running a campaign, I’d invest more in going the extra mile to find a representative sample of those voters. And then I’d hire some smart quants — or Claude? — to figure out the implications for campaign strategy based on proprietary data that my competitors didn’t have access to. -Nate Silver Are these models any good? If synthetic surveys are just a new type of model, the next obvious question is whether the models are at least accurate. The answer very much depends on who you ask. On one end of the spectrum, you have the maximalist argument that synthetic sampling is more accurate than actual polls. “It’s an incredibly challenging problem to go to someone and say ‘hey, we’re going to be more accurate at predicting human behavior than you, even when you talk to your customers directly’,” Koh recently told CNBC. In his view, synthetic sampling isn’t a saw to polling’s hammer, it’s “magic.” There’s certainly evidence that synthetic samples can replicate certain survey toplines. But if Aaru does have any examples of their approach outperforming the polls, they’re keeping those to themselves.5 Aaru’s 2024 election model, for example, had Kamala Harris leading in Michigan, Nevada, Pennsylvania, and Wisconsin on November 4th. And although they’ve since taken down their forecast page, they gave Harris a 50.5 percent chance of winning the race on November 2nd.6 After the election, Fink told Semafor he was happy enough with those results because they were “within margin of error,” a term that is completely meaningless when applied to a “sample” of AI agents. And of course, Aaru says their models have improved since 2024, so supposedly now they’d be more accurate than the polls? Still, their stronger argument is on cost: “We are significantly faster and cheaper than traditional polling, and still more accurate,” said Fink. The first two claims are undeniably true, but the third brings us to the opposite end of the spectrum. Both Jackson and Hagner are skeptical that these models are reliable for anything beyond replicating common survey toplines. “I just […] don’t think the machines are what we want when we’re looking for nuanced views. My example on this is people in Arizona and Nevada in 2024 who voted for Trump and voted for expanding abortion in their states on ballot initiatives,” said Jackson. Hagner identified another issue. Maybe the synthetic respondents, like sycophantic LLMs, are inhuman in one important way: they’re too nice. “The reports that have come through at the meetings that I’ve been at are that the early experiments on this, they cannot get respondents to be as racist or sexist or, frankly, as negative as human respondents,” he said. Academic research mostly agrees on this point. While there are some papers that show promising results when using LLMs to replicate polling data, most show that LLMs suffer from various quirks like producing too few “don’t know” responses and can seriously overpredict the favorability of politicians like Donald Trump and Kamala Harris. They also seem to struggle with too little variation between demographic subgroups, so the difference in predicted opinion between Democrats and Republicans, for example, is too small. When I asked Warner about these studies, his response to these papers was that just because academics can’t get synthetic sampling to work doesn’t mean that the technique doesn’t work in general. “Actually, the argument is, okay, yours does not [work]. That does not mean […] for this complex set of machinery, which uses a lot of investment, a lot of time, a lot of money, you can’t get it to work.” Cards on the table, I’m somewhat sympathetic to this argument because academics aren’t exactly great at making election forecasts. Usually, the people with skin in the game are the most accurate. Warner’s argument is that the approach Electric Twin takes — which includes, for example, making multiple predictions for each synthetic respondent using different models and prompts and subsequently averaging those to get a final prediction in a sort of ensemble forecast — produces better results than the simpler academic models. Warner shared a comparison between his method and the method from a recent academic paper with me, and Electric Twin was indeed able to get more accurate replication. But even still, he acknowledged that synthetic sampling “is not a crystal ball.” “If you asked me, do I think using other data sources will be more accurate than asking somebody who they will vote for, I would probably say no. But if you asked me ‘would your system be useful for our turnout modeling today?’ I would say yes.” For better or worse, it looks like the method is already getting more popular in the market research world. Most of the clients Aaru touts these days are businesses like EY and McDonald’s. And AI will probably begin to pop up in other parts of the political polling process. Pollsters are already using it to code open-ended survey responses, and some firms, like YouGov, are testing using LLMs to ask survey respondents questions. More worryingly, one danger to actual polls is that AI agents can be used to infiltrate online surveys. Most online polls use various checks to prevent that from happening, but there’s conflicting evidence on how effective those filters are and how prevalent AI agents currently are in online panels. If those agents ever become impossible to detect, it might spell the end of online polling, but the solution isn’t to replace all of your respondents with ChatGPT. Silver Bulletin is a reader-supported publication. To receive new posts and support our work, consider becoming a subscriber. Subscribe 1 That particular poll obviously doesn’t meet Silver Bulletin standards for aggregation. But we exclude all Public Sentiment Institute polls from our averages because we classify them as an amateur polling firm. 2 You could argue that Fink meant the next presidential election, but (a) I’m also confident we’ll still have real polls in 2028 and (b) in that case he should have asked an LLM to define “general election.” 3 Quick caveat: that’s reporting from a Democratic pollster. It’s possible that Republicans are more willing to use AI in political campaigns. 4 Indeed, Silver Bulletin does not include “polls” produced by MRP in our forecasts or averages, and we think it’s extremely misleading when their practitioners describe them in a way that suggests original data had been collected among a large number of states or Congressional districts. 5 A recent report from Aaru and EY did show two examples of a synthetic estimate being closer than a survey to a real-world benchmark — but I’d take those findings with a grain of salt because the report reads more like an ad and didn’t involve any sort of prediction being made ahead of time. 6 For comparison, our odds for Harris on the same day were 48.2 percent.
Your nose could detect Alzheimer’s years before symptoms begin
Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing.
Six Flags Entertainment Corp (FUN): Leadership Changes Increase Operating Agency
Six Flags Entertainment Corp (NYSE:FUN) is one of the small cap stocks that make up 0.28% of George Soros stock portfolio. On April 1, Oppenheimer maintained its Outperform rating on Six Flags Entertainment Corp (NYSE:FUN) stock but lowered the price target to $26 from $40. According to the equity research firm, a new chief executive […]
Picture this: A raffle offers a Picasso for 100 euros to fund Alzheimer’s research
A raffle in France offers the chance to win a Picasso portrait for a 100-euro ticket | 1010 WINS
Scientists say we’ve been treating Alzheimer’s all wrong
Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system.
Women’s Brains Are a $1 Trillion Opportunity
Women’s health is a macroeconomic opportunity we have ignored, write Lisa Mosconi and George Vradenburg.
African American Health Symposium highlights support for those impacted by Alzheimer's
This year's theme: "It Takes a Village: Faith, Family and Community in Caregiving."
Scientists just found a hidden “drain” inside the human brain
A hidden waste-removal pathway in the brain has finally been caught in action. Using cutting-edge MRI scans, researchers discovered that fluid flows along the middle meningeal artery in a slow, lymphatic-like pattern—very different from blood. This confirms the presence of a previously unknown drainage hub in humans. The finding could transform how scientists approach brain aging, injury, and diseases like Alzheimer’s.
Apple MacBooks slow down after 49 days due to "macOS time bomb"
The Apple MacBook, iMac and Mac mini suffer from a macOS bug that effectively acts like a time bomb. After a timer reaches a certain value, new TCP connections can effectively no longer be established, causing many apps and websites to stop working.
Masters primer: 70 years ago, tournament televised for first time; Tuesday TV times
The Masters at … 70
Older adults with high-dose flu shot had lower risk of Alzheimer’s, study shows
Experts reveal hidden link between poor sleep and Alzheimer's disease risk
A new study links tau pathology to disrupted sleep in Alzheimer's disease. Sleep expert Dr. Wendy Troxel discusses how critical sleep is for brain health.
World champion magician to perform at science museum
BUFFALO, N.Y. (WIVB) — A world champion magician held a special dress rehearsal at the Buffalo Museum of Science on Monday ahead of a week of performances in Buffalo. Jason Latimer is the man…
Microsoft calls Copilot ‘entertainment only’ while charging $30 a month for it
Microsoft's Copilot Terms of Use label it "for entertainment purposes only", yet the company charges up to $30/user/month and has spent $80bn on AI. Only 3.3% of users are paying.
Surprising links between autism, Alzheimer’s could change how we treat both
The idea that two conditions at opposite ends of life might be biologically linked is beginning to upend long-standing assumptions in brain science, blurring a divide that has shaped the field.
Surprising links between autism, Alzheimer’s could change how we treat both
The idea that two conditions at opposite ends of life might be biologically linked is beginning to upend long-standing assumptions in brain science, blurring a divide that has shaped the field.
'SNL' recap: Jack Black joins the Five-Timers Club
Jack Black returns to Studio 8H to host 'Saturday Night Live' for the fifth time, while Jack White makes his sixth turn as musical guest.
Nose-Picking May Have a Surprise Link With Alzheimer's, Study in Mice Suggests
Do you really need to pick it?
Colo Colo face Concepción to defend top spot
Colo Colo comes into the Liga de Primera in great form, where it will resume action this Sunday against Deportes Concepción. El Cacique will resume its campaign with five wins and two losses, which...
Microsoft says Copilot is for entertainment purposes only, not serious use — firm pushing AI hard to consumers tells users not to rely on it for important advice
These might be boilerplate disclaimers, but they kind of contradict the company's ads and marketing.
Cowboys news: What Mike McCarthy said about Brian Schottenheimer
Check out today’s latest and greatest news surrounding America’s team!
Stocks to buy in 2026: 12 small- and mid-caps headed for gains
Analysts at Oppenheimer selected 12 smid-cap stocks they believed had a bullish uptrend through the rest of the year.
FIU Alzheimer’s breakthrough advances to national finals of science competition ‘STAT Madness’
Representing FIU in this year’s STAT Madness finals is a research team from the Robert Stempel College of Public Health & Social Work, led by Tomás R. Guilarte (right), dean of Stempel College,...
Women get Alzheimer’s more often than men: Five things the science tells us
Women develop Alzheimer’s disease at higher rates than men. Stanford Medicine neurologists explain what science knows about why and the many things it doesn’t yet know.
Surprising study shows Alzheimer's may start in the body instead of the brain, a discovery that turns medical science upside down
Alzheimer’s disease may begin outside the brain, with inflammation in organs like the skin, lungs, and gut decades before symptoms appear.
Fantasy Basketball Week 23 Schedule Primer: It's championship week!
For managers competing in Yahoo! default leagues, Week 23 is the biggest week of the season.
Herkimer BOCES honors program explores Civil War
Herkimer BOCES honors students explored Civil War history through storytelling, writing and presentations during a March 23 workshop.
MSU hockey's season ends in heartbreaking overtime loss to Wisconsin
Wisconsin's Ben Dexheimer scored just 24 seconds into overtime to send the Badgers to the Frozen Four.
Classic clash
Blair County’s Makenna Weimert makes a pass over Central Pa.’s Zayona Thomas during the girls game of the 19th annual Altoona Mirror Basketball Classic. Mirror photo by Patrick Waksmunski
Impossible Science Live! with World Champion of Magic Jason Latimer
Impossible Science Live! with World Champion of Magic Jason Latimer From bending light with physics, to shaping water with chemistry and walking through solid glass with engineering, World Champion of Magic Jason Latimer’s mind-blowing live show delivers an inspiring message of how “The right question changes everything.” Impossible Science LIVE! expands on Jason Latimer’s inspiring TED Talk “ Seeing Beyond the Illusion of Knowledge ” with family-friendly, mind-blowing illusion entertainment. Uniting his favorite illusions from his illustrious career, Latimer reveals the secret to his magic is not special powers but simply a pursuit of challenging the impossible with curiosity. During your museum visit from April 7-11, 2026, drop into the auditorium for one of Latimer’s shows throughout the day. Shows are included with your Spring Break admission and FREE for museum members. Add a membership to your cart for free Spring Break admission! Available showtimes: 10:30 a.m., 11:30 a.m., 1 p.m., 2 p.m. daily, with a 3:30 p.m. show on Saturday, April 11. Open seating; first come, first seated. About Jason Latimer: Jason Latimer has been featured on television around the world as both a scientist and magician. While Latimer is both a curator of the iconic Fleet Museum in San Diego, CA, and a World Champion Magician his network specials, TV series, and appearances span the globe. Jason has been featured as a science host on the Science Channel, Roku, Amazon, and as a magician on the Syfy Channel, History, BBC ONE, and Japan’s NHK. In 2021, SONY partnered with Latimer to bring his unique blend of science and magic to online and to PBS to assist with distance learning. Impossible Science’s growth has been exponential ever since, garnering over a hundred million views and multiple streaming awards as an educational series.
Innovation at the Intersections of HIV and Brain Health
amfAR research staff discuss brain health, such as HAND and Alzheimer’s, as people age with HIV and the scientific advances in treatment needed.
Mass. woman diagnosed with Alzheimer's in 30s told 'too young' for drug by insurance
A Massachusetts woman with early onset Alzheimer's fought her insurer over a denied treatment, raising questions about age limits and access to care.
The brain's cleaning system can be boosted to rid Alzheimer's proteins
A duo of drugs that boosts our glympathic system, which clears waste from our brain, also improves the removal of proteins associated with the onset of Alzheimer's disease
PHOTO RELEASE: Gottheimer Tours Atlantic Health’s Newton Medical Center
Above: Congressman Gottheimer Tours Newton Medical Center NEWTON, NJ — U.S. Congressman Josh Gottheimer (NJ-5) toured Atlantic Health System’s Newton Medical Center and met with hospital leadership to discuss improving access to health care, supporting our health care workers, and ensuring New Jersey families continue to receive the high-quality care they deserve. During the visit, Gottheimer […]
Scientists Call for a Complete Rethink of Alzheimer’s Treatment
New insights suggest that Alzheimer’s cannot be tackled through a single pathway, as its roots extend across molecular, genetic, and systemic processes.
Scientists say NAD+ could slow aging and fight Alzheimer’s and Parkinson’s
A global team of leading scientists is zeroing in on a tiny but powerful molecule that could reshape how we age. Known as NAD⁺, it plays a crucial role in keeping our cells energized, repairing DNA, and maintaining overall health—but its levels steadily decline over time, potentially fueling diseases like Alzheimer’s and Parkinson’s. Researchers are now exploring ways to boost NAD⁺ using compounds like NR and NMN, with early studies hinting at improvements in memory, metabolism, and physical function.
Nasal swab may catch Alzheimer's disease earlier — here's how it works
Outgoing MSPs leave Holyrood with relief, regret and unfinished business
A record 42 MSPs are stepping down, from grandees to first timers - they share their reasons why.
Exclusive: Dimer Health raises $13.5M for patient discharge
The round gives Dimer approximately three years of runway, though it will begin having initial conversations about its next round soon.
Men are losing a key chromosome with age and it may be deadly
Aging men often lose the Y chromosome in a growing number of their cells—and it may be far more dangerous than once believed. This loss has been linked to heart disease, cancer, Alzheimer’s, and shorter lifespans. Researchers suspect Y-less cells may grow faster and disrupt normal body functions. What seemed like a minor genetic quirk could actually be a major driver of age-related disease.
Sports quiz of the week: youngsters, old timers, records, protests and posh grub
Have you followed the big stories in football, rugby, golf, baseball, horse racing, winter sports, F1, snooker and more?
Nasal Swab Test Spots Early Alzheimer’s Signals
DURHAM, N.C. – Alzheimer’s disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new treatments may work best.In a new study, Duke Health researchers show that a quick, outpatient nasal swab can pick up early biological changes linked to Alzheimer’s, even before thinking and memory problems appear.
The Gemini for Home voice assistant is now more concise, faster, & better at alarms/timers
Google is back with a second big update to Gemini for Home this month that notably improves the voice assistant.
Epstein urged media mogul to give up control of affairs, citing health
Late sex offender urged US-Canadian billionaire Mortimer Zuckerman to enter guardianship or conservatorship, files show.
Haims: Jujube(s) have health benefits for sleep, Parkinson’s and Alzheimer’s
If you’re old enough to remember enjoying a box of Jujubes at the movie theater, you’re old enough to question this article’s title. If not, here’s the scoop. For decades, Jujubes candy was a movie theater staple. They look like very short rabbit pellets, similar in size and...
What are peptides, and are they safe? Here's what to know
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.
The US slashed research for cancer, Alzheimer’s, mental health — and nearly everything else
Revealed in one chart.
Gen. Herkimer's Role in Battle of Oriskany Explored in New Play
There is a new play exploring the pivotal Battle of Oriskany and General Herkimer.
MAHA courts women voters at HHS health event
What do an Alzheimer’s researcher and Miss America’s Teen 2026 have in common?
From cancer to Alzheimer's, high school students seek science solutions
Woo! Science is honored to present the Community Impact Award to winners at the Worcester Regional Science and Engineering Fair.
Single protein could dramatically alter trajectory of Alzheimer's disease
In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.
N.Y. congressman pushes back with election legislation
The announcement comes when President Donald Trump has increasingly focused on election reform.
Herkimer business owner arrested on numerous charges following fraud investigation
A Herkimer business owner turned himself in after an investigation into fraud incidents in Otsego County.
Jerry Bruckheimer Holds the Line on Entertainment for Everyone
The producer says it’s not just the movies that need saving.
Exercise Protects Against Alzheimer's, And Scientists May Finally Know Why
A crucial chain reaction.
Scientists Cut Amyloid Plaques by 50% in Mice With Engineered Cells
"This study marks the first successful attempt."
Poor brain health costs the world economy $5 trillion a year. The world is waking up to the crisis
I'm the founding chairman of the Davos Alzheimer’s Collaborative and I see a difference this year: the world is realizing that brains are infrastructure.
Cowboys news: Brian Schottenheimer’s coaching style has been refreshing
The latest news around the Dallas Cowboys
The Dazey Phase Boards Best Yet Entertainment Co-Founder Kareem J. Mortimer’s ‘House On Fire’
EXCLUSIVE: New York State-based production, sales and distribution company The Dazey Phase has boarded Bahamian director Kareem J. Mortimer’s upcoming psychological thriller House On Fire. The Dazey P...
Linus Health to Present New Findings on Digital Risk Scores for Dementia and Patient-Centered Endpoints at Leading Global Alzheimer's and Parkinson's Conference
Linus Health will present new research at a leading global Alzheimer's and Parkinson's Diseases conference, revealing how advanced insights from digital cognitive assessments and personalized outcome measures may help transform how patients are identified for emerging therapies and how treatment impact is measured in ways that reflect patients' personal priorities.
Scientists just found the brain’s hidden defense against Alzheimer’s
A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments.
PHOTO RELEASE: Gottheimer Honors Black History Month, Joins Bergen County’s Black History Month Health Fair
Above: Gottheimer at Bergen County’s Black History Month Health Fair. HACKENSACK, NJ — Today, February 28, 2026, U.S. Congressman Josh Gottheimer (NJ-5) honored Black History Month and joined with the local community for the Bergen County Black History Month Health Fair. The event brought together local organizations, health professionals, and families to promote wellness, raise […]
Scientists Uncover the Secret Structure Behind “Nature’s Proton Highway”
By freezing a crucial phosphoric acid complex to near absolute zero, scientists uncovered a single, unexpectedly stable structure at the heart of proton transport.
As Alzheimer’s cases rise in Oregon, free Portland conference offers families tools and support
Nearly 80,000 Oregonians are living with Alzheimer’s disease and numbers are expected to increase as the population ages.
Social science research on collective action wins National Science Foundation grant
Social scientist Nils Reimer and his team have secured a three-year National Science Foundation award to study double standards in how people judge protests according to idealogical affiliations.
Seatmate politics - Live Updates
So much for interparty solidarity. Reps. Thomas Massie (R-Ky.) and Ro Khanna (D-Calif.), who earlier in the day telegraphed plans to sit together during the State of the Union, have evidently abandoned that idea. State of the UnionMassie wrote on X before Trump’s address that he was seated on the Republican side of the chamber. Khanna is sitting next to former House Speaker Nancy Pelosi. But Reps. Mike Lawler (R-N.Y.) and Josh Gottheimer (D-N.J.), who often work together, are seated together along with some other Republicans. Mia McCarthy contributed to this report.
How One Gene Affects Alzheimer’s Risk | Science Friday
An estimated 500,000 people are diagnosed with Alzheimer’s disease in the United States each year, but the causes and mechanisms of the condition remain a neurological mystery. A rece...
Study identifies medical conditions that could predict future Alzheimer’s disease
The findings could suggest ways to intervene before clinical symptoms of Alzheimer's disease become apparent.
How I booked my first business-class flight with points
These are the steps I took to book my first business-class flight with Virgin Atlantic for a trip to London, including how I transferred Amex points for the redemption.
Simple blood test can forecast Alzheimer’s years before memory loss
Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care.
Simple, day-to-day tasks may delay Alzheimer’s and dementia, scientists say
The survey, one of the largest of its kind, promotes the idea that the texture of daily life can leave a measurable imprint on the aging brain.
Common pneumonia bacterium may fuel Alzheimer’s disease
A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline.
UT Health San Antonio researcher earns grant to study how the brain’s immune cells might actually contribute to Alzheimer’s - UT Health San Antonio
Cure Alzheimer’s Fund award aimed at better understanding microglia’s role Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Feb. 20, 2026 – A researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimer’s Fund to study how microglia, […]
Scientists reveal how exercise protects the brain from Alzheimer’s
Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies.
Susan Blanco new Colorado Supreme Court justice
Chief Judge Susan Blanco of Larimer and Jackson counties is the newest member of the Colorado Supreme Court, Gov. Jared Polis announced on Tuesday. “A few words come to mind: Innovation. Excellence. Creativity. Hard work. These are values we need across society,” said Polis during a news conference announcing Blanco’s appointment. Blanco, 48, became a […]
Episode 51: We Are in the Pain Cave of Politics
Carrie, Amy and Matthew join the Roundtable this week. First, Amy takes a look at Trump's sagging approval ratings among white working-class voters and what that could mean for the midterms. Then, Matthew gives a primer on this year’s races for secretary of state and other election offices that will wield significant influence over how the 2028 and 2030 cycles are administered.And finally, the team discusses which winter Olympic sport they would want to compete in and who would like to experience what it means to be "in the pain cave."
Susan Blanco is the next Colorado Supreme Court justice
Chief Judge Susan Blanco of Larimer and Jackson counties is the newest member of the Colorado Supreme Court, Gov. Jared Polis announced on Monday. Blanco, 48, became a district judge in January 2017. She will join four other former trial judges, including two other former chief judges, on the seven-member Supreme Court. Blanco is Polis’ […]
The Link Between Air Pollution And Alzheimer's Is Now Clearer Than Ever
The air we breathe is harming us.
Scientists discover brain switches that clear Alzheimer’s plaques
Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.